Taro Pharmaceuticals is a global leader in generic and specialty pharmaceuticals, renowned for its expertise in dermatology and vertically integrated manufacturing across the US, Canada, Israel, and beyond.
Import Shipments
Distribution Centers
Annual Revenue
Founded
Taro Pharmaceuticals is likely focused on expanding its dermatology portfolio, enhancing supply chain resilience, and integrating operations with Sun Pharma to drive innovation and global market growth.
Expansion of dermatology and specialty product lines to address evolving patient needs
Strategic efforts to expand market presence and reach new customer segments.
Implementation of advanced technologies to improve service delivery and customer experience.
Taro Pharmaceuticals develops and manufactures a broad portfolio of generic, branded, and OTC pharmaceutical products, with a particular strength in dermatology and topical formulations. The company is vertically integrated, producing both APIs and finished dosage forms, which ensures quality control and supply chain reliability. Taro markets over 300 finished goods and supplies APIs for more than 100 SKUs, serving physicians, pharmacists, and patients worldwide. As a wholly owned subsidiary of Sun Pharma, Taro leverages global resources and expertise to maintain its leadership in the pharmaceutical industry.
Haifa, Israel
1950
Private company
